These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2550123)

  • 21. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
    Ward JM; Perantoni AO; Santos E
    Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor alpha expression in normal gastric mucosa, intestinal metaplasia, dysplasia and gastric carcinoma--an immunohistochemical study.
    Nasim MM; Thomas DM; Alison MR; Filipe MI
    Histopathology; 1992 Apr; 20(4):339-43. PubMed ID: 1577411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical and immunoblot analyses of ras-p21 expression in lung carcinomas.
    Koshiishi Y; Noguchi M; Nakajima T; Hirohashi S; Shimosato Y; Hayata Y
    Acta Pathol Jpn; 1989 Oct; 39(10):643-7. PubMed ID: 2686349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of p185erbB2 and p21ras in carcinoma, dysplasia, and intestinal metaplasia of the stomach: an immunohistochemical and in situ hybridization study.
    Li J; Zhao A; Lu Y; Wang Y
    Semin Surg Oncol; 1994; 10(2):95-9. PubMed ID: 7914379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histogenesis of intestinal and diffuse types of gastric carcinoma.
    Laurén P
    Scand J Gastroenterol Suppl; 1991; 180():160-4. PubMed ID: 2042032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of ras oncogene p21 during human fetal development as determined by monoclonal antibodies RAP-5, Y13-259, and DWP.
    Radosevich JA; Combs SG; Ma Y; Lee I; Gould VE; Thor A; Schlom J; Carney WP; Rosen ST
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(5):337-44. PubMed ID: 2565631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of ras oncogene p21 protein in relation to regional spread of human breast carcinomas.
    Czerniak B; Chen R; Tuziak T; Markiewski M; Kram A; Gorczyca W; Deitch D; Herz F; Koss LG
    Cancer; 1989 May; 63(10):2008-13. PubMed ID: 2467732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between expression of tumor suppressor protein p21 and p53 and cell proliferation in the gastric carcinoma].
    Huang J; Gan J
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(5):441-3. PubMed ID: 10682555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oncogenes in human gastric carcinoma].
    Tahara E
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2149-55. PubMed ID: 2544146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative evaluation of dysplasia and early cancer of the stomach based on analysis of DNA content].
    Zolotarevskiĭ VB; Sklianskaia OA
    Arkh Patol; 1984; 46(11):58-66. PubMed ID: 6098243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis.
    Tahara E; Yasui W; Taniyama K; Ochiai A; Yamamoto T; Nakajo S; Yamamoto M
    Jpn J Cancer Res; 1986 Jun; 77(6):517-22. PubMed ID: 3089984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study.
    Falck VG; Gullick WJ
    J Pathol; 1989 Oct; 159(2):107-11. PubMed ID: 2572685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent overexpression, but not activation by point mutation, of ras genes in primary human gastric cancers.
    Fujita K; Ohuchi N; Yao T; Okumura M; Fukushima Y; Kanakura Y; Kitamura Y; Fujita J
    Gastroenterology; 1987 Dec; 93(6):1339-45. PubMed ID: 3315826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P21 protein expression and ras-oncogene mutations in gastric carcinoma: correlation with clinical data.
    Kasper HU; Schneider-Stock R; Mellin W; Roessner A
    Int J Oncol; 1998 Jan; 12(1):69-74. PubMed ID: 9454888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of Cdx-2 homeobox gene in intestinal metaplasia and gastric adenocarcinoma].
    Paik CH; Han DS; Lee SH; Chung YW; Kim JP; Sohn JH; Hahm JS; Oh YH; Park YU
    Korean J Gastroenterol; 2004 Oct; 44(4):186-92. PubMed ID: 15505429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development.
    Sasaki I; Yao T; Nawata H; Tsuneyoshi M
    Cancer; 1999 Apr; 85(8):1719-29. PubMed ID: 10223565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prostaglandin E (PGE) and gastric carcinoma].
    Fu QL; Yang MF; Li ZJ; Jiang YY; Song SB; Song TH; Wang HX
    Zhonghua Zhong Liu Za Zhi; 1986 Sep; 8(5):345-8. PubMed ID: 3032544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
    Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
    Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice.
    Mutoh H; Sakurai S; Satoh K; Osawa H; Hakamata Y; Takeuchi T; Sugano K
    Gut; 2004 Oct; 53(10):1416-23. PubMed ID: 15361487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary.
    Kuwashima Y; Shisa H; Uehara T; Kurosumi M; Kobayashi Y; Tanuma J; Shiromizu K; Matsuzawa M; Kishi K
    Anticancer Res; 1995; 15(6B):2847-50. PubMed ID: 8669877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.